MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. Here is what the mouse, cell and human observational studies show about its folate-AMPK mechanism, nuclear signaling and exercise link, and what is still unresolved.
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. It was described in 2015 by Changhan Lee, Pinchas Cohen and colleagues at the University of Southern California, who reported that it regulates insulin sensitivity and metabolic homeostasis in mice [1]. It has since become one of the best-studied mitochondrial-derived peptides. This guide covers where MOTS-c comes from, how it is thought to work, what has been shown in cells, mice and human observational studies, and the questions that remain open.
Human mitochondrial DNA is usually described as encoding 37 genes: 22 tRNAs, 2 rRNAs and 13 protein-coding mRNAs [5]. The discovery of humanin, and then MOTS-c, showed that short open reading frames inside this small circular genome can also yield signaling peptides [5]. A 2022 review counted eight published mitochondrial-derived peptides: humanin, MOTS-c and the six small humanin-like peptides (SHLP1-6) [8].
MOTS-c has the sequence MRWQEMGYIFYPRKLR. Because mitochondrial DNA is inherited through the maternal line, its sequence travels with mitochondrial haplogroups. One naturally occurring variant, m.1382A>C, found in East Asian populations, changes lysine 14 to glutamine (K14Q) in the peptide [4]. That variant has turned out to be a useful natural experiment, discussed below.
In the discovery paper, skeletal muscle appeared to be the primary target tissue [1]. In cultured cells, MOTS-c inhibited the folate cycle and the de novo purine synthesis pathway tethered to it. The resulting build-up of the purine intermediate AICAR, a known endogenous activator of AMP-activated protein kinase (AMPK), led to AMPK activation [1]. AMPK is the cell's central energy sensor, and its activation shifts metabolism toward glucose uptake and fatty acid oxidation.
In 2018 the same group reported that MOTS-c moves into the nucleus in response to metabolic stress such as glucose restriction, in an AMPK-dependent manner [2]. Once there, it influenced a broad set of genes, including those carrying antioxidant response elements, and interacted with stress-responsive transcription factors such as NRF2 [2]. The authors framed this as a mitochondrial-encoded factor directly regulating the nuclear genome, reversing the usual direction of control between the two genomes [6]. These observations come from cultured cells, and a later human muscle study did not find MOTS-c expression associated with antioxidant-response genes in the way seen in culture [7].
In the 2015 study, mice given MOTS-c were protected against both age-dependent and high-fat-diet-induced insulin resistance, and against diet-induced obesity [1]. A 2021 study extended this to physical capacity: MOTS-c enhanced physical performance in young (2 months), middle-aged (12 months) and old (22 months) mice, and intermittent exposure started late in life, at 23.5 months, increased physical capacity and healthspan measures [3]. In that work MOTS-c also regulated nuclear genes related to metabolism and proteostasis and supported myoblast adaptation to metabolic stress [3].
The K14Q variant study added an important nuance. In high-fat-fed male mice, native MOTS-c reduced weight and improved glucose tolerance, while the K14Q form did not; female mice were unaffected by either [4]. Sex is therefore a variable to design for, not an afterthought.
The human literature on MOTS-c is observational. It measures the body's own peptide or examines genetic variation; it does not test administered MOTS-c, and it should not be read that way.
The aging data in particular complicate the simple story that MOTS-c just declines with age. Plasma and muscle appear to be regulated differently [7], so a single blood measurement says little about what is happening in tissue.
MOTS-c is often called an exercise mimetic because, in mice, it reproduces some metabolic features of physical training, and because exercise raises the body's own MOTS-c in humans [3]. That is a research hypothesis about part of the exercise response, not evidence that the peptide substitutes for exercise. Exercise changes hundreds of signals across many tissues; MOTS-c is one candidate among them, and the human evidence for its role remains correlational.
In cell work, researchers commonly use myoblasts or differentiated myotubes and measure glucose uptake, AMPK phosphorylation and its downstream target ACC by western blot, mitochondrial respiration by extracellular flux analysis, and folate and purine intermediates by metabolomics [1]. Nuclear translocation is followed by cell fractionation or imaging after glucose restriction or oxidative stress [2]. In mice, diet-induced obesity models with glucose and insulin tolerance testing, and treadmill or grip-based performance measures across age groups, are the standard readouts [1][3].
Two design choices are worth borrowing from the literature. A scrambled-sequence peptide is the usual negative control, and the naturally occurring K14Q variant offers a closely matched peptide with reduced insulin-sensitizing activity in vitro [4]. Including both sexes, and measuring MOTS-c in tissue as well as plasma, avoids the most common interpretive traps.
MOTS-c is a 16-residue peptide of about 2,174 Da. Its sequence contains two methionines and a tryptophan, residues that oxidize readily, and several basic arginine and lysine residues, which can make the peptide stick to some surfaces. Store the lyophilized powder at -20 °C, sealed and dry, and let the vial reach room temperature before opening. Dissolve it in sterile water or the buffer your assay requires, keep air exposure brief, use low-binding tubes for dilute solutions, and freeze single-use aliquots rather than thawing and refreezing one stock. For oxidation-sensitive work, mass spectrometry will show whether methionine oxidation (a +16 Da shift) has occurred.
Northbridge Research Labs sends every batch for independent third-party testing. Where a lot's certificate has been published, you will find it on our COA page; certificates are posted online and are not printed in the box.
Note: MOTS-c from Northbridge Research Labs is supplied for laboratory research use only. It is not for human or veterinary use. Human findings described here come from observational studies of the body's own MOTS-c, not from use of this material.
Studied compound
MOTS-c
The same material this research covers — 99%+ purity, independently tested, with the certificate for each batch published online.
How a single trans-3-hexenoyl group turns native GHRH into a longer-lived analogue, what the phase 3 and liver-fat trials actually found, what preclinical work showed, and how to handle tesamorelin in the lab.
What sermorelin acetate is, where the 29-residue fragment came from, how it acts at the GHRH receptor, how it compares with native GHRH, tesamorelin, CJC-1295 and ipamorelin, and how to handle it in the lab.
How retatrutide-type triple agonism at the GLP-1, GIP and glucagon receptors was designed, what the published rodent and phase 2 literature reports, and which questions remain open for laboratory study.
Research Use Only: The information in this article is for educational and research purposes only. All products mentioned are intended for laboratory research use only and are not approved for human or veterinary use.